- News & Analysis
- Home
- Latest News
- Reports
- Podcasts
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Job Postings
- Events
Page 312
Kyn Therapeutics binds Celgene investment
UT Austin-founded Kyn Therapeutics has been backed by Celgene in a strategic pact that also includes a $80m non-equity payment, giving Celgene the right to license two programs.
Jan 18, 2019Findologic discovers fresh capital
The seven-digit investment by BE Beteiligungen Fonds will help Salzburg e-commerce search spinout Findologic accelerate its international expansion and introduce new product features.
Jan 17, 2019Daphne fertilises $4.9m
EPFL-founded exhaust filtering system spinout Daphne Technology has been backed by investors including oil producer Saudi Aramco.
Jan 17, 2019Waterloo puts Velocity behind angel fund
University of Waterloo hopes to raise $1.2m to $1.8m for an angel fund to make equity investments in the winners of its Velocity Fund Finals competition.
Jan 17, 2019UNLV touts Food Genes and Me
Dietary suggestion software spinout Food Genes and Me compiles personalised healthy eating tips based on uploaded DNA reports from external genetic analysis tools.
Jan 17, 2019Purdue Ag-celerator seeds $100,000
Plant sciences startups Heliponix and Karyosoft each secured $50,000 investments after winning the fifth cohort of Purdue’s Ag-celerator competition.
Jan 16, 2019Kerionics pumps in $228,000
Partly based on Polytechnic University of Valencia research, Kerionics hopes to commercialise a ceramic membrane-based system for producing industrial quantities of oxygen from waste gases.
Jan 16, 2019Winningtemp calls Chalmers for $3.7m round
Chalmers Ventures has invested more funding in human resources app developer Winningtemp, which is preparing its employee wellbeing software for international expansion.
Jan 15, 2019NYU and Futurx spark Glixogen’s genesis
New York University has teamed up with corporate-backed biopharmaceutical incubator Futurx to spawn neurodegenerative disease drug developer Glixogen Therapeutics.
Jan 15, 2019Samsung trains its focus on Corephotonics
Samsung is reportedly eyeing Tel Aviv University-founded smartphone camera technology developer Corephotonics for $150m to $160m after backing its series B and C rounds.
Jan 15, 2019About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits our membership, providing privileged access to all our services and resources.
Navigation
test regLogin
Not yet subscribed?
We use cookies to enhance your browsing experience and analyse our traffic. By clicking "Accept All", you consent to our use of cookies. Accept Read MorePrivacy & Cookies PolicyPrivacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.


